Gustave Roussy Institut to use blockchain for data in cancer drug trials

The Gustave Roussy Institut, a cancer centre in France, is to deploy blockchain in data-sharing applications for oncology research. The technology will be built in partnership with Embleema, a developer of a healthcare blockchain network, and will be used to improve transparency, patient safety and patient engagement in clinical trials.

Global collaboration publishes recommendations to speed rare disease diagnosis

The Global Commission to End the Diagnostic Odyssey for Children has today published recommendations on how to solve the challenge of diagnosing rare diseases. The commission was set up by Takeda, Microsoft, and EURORDIS-Rare Diseases Europe to find solutions to core barriers preventing timely diagnosis for rare diseases.
New NHSX to drive digital transformation of NHS
The UK's Department for Health is launching NHSX, a new unit with responsibility for setting national policy and developing best practice for NHS technology.
Alex Guest Tue, 19/02/2019 - 17:35
Inovia Capital raises $600m venture funds
Inovia Capital, the Canadian VC firm, has raised two new funds totalling US$600 million: an early-stage fund of $200 million; and a growth-stage of $400 million. The funds will be invested in its existing markets in Canada and Silicon Valley, as well as through a new office in London.
Alex Guest Tue, 19/02/2019 - 16:08

Vicarious Surgical raises $10m for product development

Vicarious Surgical, a company working on minimally-invasive surgery, has raised a further $10 million from Gates Frontier, Khosla Ventures, Innovation Endeavours, AME Cloud Ventures, and Marc Benioff.

HIMSS19 focus on value-based care

At HIMSS19, one theme seems to filter through all the buzz and activity: delivering value-based, patient-centred care.